Acute promyelocytic leukaemia: urgent assessment and referral

Suspected acute promyelocytic leukaemia (APL) is a reason for urgent specialist care. It should not be handled as a routine medical-travel enquiry. If a doctor or laboratory has raised this possibility, communicate it immediately to the responsible haematology or emergency team and follow their instructions.

Why the exact subtype matters immediately

APL is a subtype of acute myeloid leukaemia associated with a characteristic PML::RARA finding. The NCI describes serious bleeding and clotting problems that can occur and emphasises rapid treatment. Its treatment approach differs from that of other AML subtypes, which is why the exact suspicion must be communicated promptly.

The family should not wait to collect every report or arrange a foreign consultation before contacting care. Nor should it try to start a drug found in an APL article independently. Urgent diagnosis, support and treatment decisions require the clinical team.

Relay the uncertainty accurately

Tell the receiving service whether the report states “suspected”, “consistent with” or “confirmed”, and send the original document when it is available. Include the clinician’s contact details so the teams can clarify the finding directly. Do not translate all three phrases as a confirmed diagnosis, and do not downplay an urgent suspicion because confirmation is pending.

Useful information for the first clinical contact includes the latest blood results, any bleeding symptoms, current location and treatment already started. Finding old records should not delay the call or attendance instructed by the medical team.

Keep emergency care and a later second opinion in the right order

A second opinion can later address the confirmed diagnosis, treatment phase or follow-up strategy. During the urgent initial period, ask the current doctors whether they need immediate specialist discussion with another centre. A family-organised flight is not a substitute for stabilisation or an agreed medical transfer.

• Which team is responsible for immediate care?
• What confirmation is pending and who will receive it?
• What should the family report without delay?
• Is any transfer being considered by the clinicians, and has the receiving team accepted?

Keep the answers and the emergency contact details with the current prescription list. If significant bleeding, breathing difficulty, confusion or rapid deterioration occurs, seek immediate local medical help.

Review the subsequent programme once care is established

When the team considers it appropriate, request an explanation of the treatment phases and the tests used to assess response. If treatment in Turkey is being discussed, the receiving service should review the actual care already given and confirm the clinical purpose of transfer.

Financial and travel planning should follow medical readiness. Separate the cost of any later specialist review from a proposed treatment course, and avoid paying for a generic “AML package” that does not identify the confirmed subtype and current phase. This guide is intended to support urgent communication, not to diagnose APL or specify its treatment.

Make the first message short enough to act on

If a clinician has raised possible APL, the initial communication should state that wording, where the patient is, which medical team is present and how that team can be reached. The original report can follow through the agreed channel. Do not make the urgent message depend on translating a large folder, obtaining a quotation or receiving a coordinator’s administrative reply. The clinical service needs to know the concern now.

Once urgent care is established, keep one updated account of results received and treatment already administered. Label a pending confirmation as pending and a confirmed result with its date. If two hospitals become involved, ask the doctors to exchange the current account directly. A relative can organise copies and contacts, but should not be asked to resolve conflicting clinical instructions. The next conversation about travel belongs after the teams have identified what care is needed and whether a transfer is medically appropriate.

A practical next step

For the practical arrangements, see An oncology second opinion: when it helps and how to prepare.

Sources

• NCI: Acute Myeloid Leukemia Treatment